Report Detail
Global Targeted Alpha-particle Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4741799 |
- 05 October, 2026 |
- Global |
- 83 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Targeted Alpha-particle Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
This report is a detailed and comprehensive analysis for global Targeted Alpha-particle Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Alpha-particle Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Targeted Alpha-particle Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Targeted Alpha-particle Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Targeted Alpha-particle Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Alpha-particle Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Alpha-particle Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Targeted Alpha-particle Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
Market segment by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
Market segment by players, this report covers
Bayer
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
Fusion Pharmaceuticals(AstraZeneca)
AlphaGen Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted Alpha-particle Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Alpha-particle Therapy, with revenue, gross margin, and global market share of Targeted Alpha-particle Therapy from 2021 to 2026.
Chapter 3, the Targeted Alpha-particle Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Targeted Alpha-particle Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Alpha-particle Therapy.
Chapter 13, to describe Targeted Alpha-particle Therapy research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Targeted Alpha-particle Therapy by Type
- 1.3.1 Overview: Global Targeted Alpha-particle Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Targeted Alpha-particle Therapy Consumption Value Market Share by Type in 2025
- 1.3.3 Actinium-225
- 1.3.4 Astatine-211
- 1.3.5 Lead-212
- 1.3.6 Bismuth-213
- 1.3.7 Others
- 1.4 Global Targeted Alpha-particle Therapy Market by Application
- 1.4.1 Overview: Global Targeted Alpha-particle Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Immunotherapy
- 1.4.3 Peritoneal Carcinomas
- 1.4.4 Bone Metastases
- 1.4.5 Leukaemia
- 1.4.6 Melanomas
- 1.4.7 Solid Tumours
- 1.5 Global Targeted Alpha-particle Therapy Market Size & Forecast
- 1.6 Global Targeted Alpha-particle Therapy Market Size and Forecast by Region
- 1.6.1 Global Targeted Alpha-particle Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Targeted Alpha-particle Therapy Market Size by Region, (2021-2032)
- 1.6.3 North America Targeted Alpha-particle Therapy Market Size and Prospect (2021-2032)
- 1.6.4 Europe Targeted Alpha-particle Therapy Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Targeted Alpha-particle Therapy Market Size and Prospect (2021-2032)
- 1.6.6 South America Targeted Alpha-particle Therapy Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Targeted Alpha-particle Therapy Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Bayer
- 2.1.1 Bayer Details
- 2.1.2 Bayer Major Business
- 2.1.3 Bayer Targeted Alpha-particle Therapy Product and Solutions
- 2.1.4 Bayer Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Bayer Recent Developments and Future Plans
- 2.2 Orano Med
- 2.2.1 Orano Med Details
- 2.2.2 Orano Med Major Business
- 2.2.3 Orano Med Targeted Alpha-particle Therapy Product and Solutions
- 2.2.4 Orano Med Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Orano Med Recent Developments and Future Plans
- 2.3 Oncoinvent AS
- 2.3.1 Oncoinvent AS Details
- 2.3.2 Oncoinvent AS Major Business
- 2.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Product and Solutions
- 2.3.4 Oncoinvent AS Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Oncoinvent AS Recent Developments and Future Plans
- 2.4 Perspective Therapeutics
- 2.4.1 Perspective Therapeutics Details
- 2.4.2 Perspective Therapeutics Major Business
- 2.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Product and Solutions
- 2.4.4 Perspective Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Perspective Therapeutics Recent Developments and Future Plans
- 2.5 Ablaze Pharma
- 2.5.1 Ablaze Pharma Details
- 2.5.2 Ablaze Pharma Major Business
- 2.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Product and Solutions
- 2.5.4 Ablaze Pharma Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ablaze Pharma Recent Developments and Future Plans
- 2.6 ARTBIO
- 2.6.1 ARTBIO Details
- 2.6.2 ARTBIO Major Business
- 2.6.3 ARTBIO Targeted Alpha-particle Therapy Product and Solutions
- 2.6.4 ARTBIO Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 ARTBIO Recent Developments and Future Plans
- 2.7 Fusion Pharmaceuticals(AstraZeneca)
- 2.7.1 Fusion Pharmaceuticals(AstraZeneca) Details
- 2.7.2 Fusion Pharmaceuticals(AstraZeneca) Major Business
- 2.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product and Solutions
- 2.7.4 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Fusion Pharmaceuticals(AstraZeneca) Recent Developments and Future Plans
- 2.8 AlphaGen Therapeutics
- 2.8.1 AlphaGen Therapeutics Details
- 2.8.2 AlphaGen Therapeutics Major Business
- 2.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Product and Solutions
- 2.8.4 AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 AlphaGen Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Targeted Alpha-particle Therapy Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Targeted Alpha-particle Therapy by Company Revenue
- 3.2.2 Top 3 Targeted Alpha-particle Therapy Players Market Share in 2025
- 3.2.3 Top 6 Targeted Alpha-particle Therapy Players Market Share in 2025
- 3.3 Targeted Alpha-particle Therapy Market: Overall Company Footprint Analysis
- 3.3.1 Targeted Alpha-particle Therapy Market: Region Footprint
- 3.3.2 Targeted Alpha-particle Therapy Market: Company Product Type Footprint
- 3.3.3 Targeted Alpha-particle Therapy Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Targeted Alpha-particle Therapy Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Targeted Alpha-particle Therapy Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Targeted Alpha-particle Therapy Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Targeted Alpha-particle Therapy Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Targeted Alpha-particle Therapy Consumption Value by Type (2021-2032)
- 6.2 North America Targeted Alpha-particle Therapy Market Size by Application (2021-2032)
- 6.3 North America Targeted Alpha-particle Therapy Market Size by Country
- 6.3.1 North America Targeted Alpha-particle Therapy Consumption Value by Country (2021-2032)
- 6.3.2 United States Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 6.3.3 Canada Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Targeted Alpha-particle Therapy Consumption Value by Type (2021-2032)
- 7.2 Europe Targeted Alpha-particle Therapy Consumption Value by Application (2021-2032)
- 7.3 Europe Targeted Alpha-particle Therapy Market Size by Country
- 7.3.1 Europe Targeted Alpha-particle Therapy Consumption Value by Country (2021-2032)
- 7.3.2 Germany Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 7.3.3 France Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 7.3.5 Russia Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 7.3.6 Italy Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Targeted Alpha-particle Therapy Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Targeted Alpha-particle Therapy Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region
- 8.3.1 Asia-Pacific Targeted Alpha-particle Therapy Consumption Value by Region (2021-2032)
- 8.3.2 China Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 8.3.3 Japan Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 8.3.5 India Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 8.3.7 Australia Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Targeted Alpha-particle Therapy Consumption Value by Type (2021-2032)
- 9.2 South America Targeted Alpha-particle Therapy Consumption Value by Application (2021-2032)
- 9.3 South America Targeted Alpha-particle Therapy Market Size by Country
- 9.3.1 South America Targeted Alpha-particle Therapy Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Targeted Alpha-particle Therapy Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Targeted Alpha-particle Therapy Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country
- 10.3.1 Middle East & Africa Targeted Alpha-particle Therapy Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
- 10.3.4 UAE Targeted Alpha-particle Therapy Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Targeted Alpha-particle Therapy Market Drivers
- 11.2 Targeted Alpha-particle Therapy Market Restraints
- 11.3 Targeted Alpha-particle Therapy Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Targeted Alpha-particle Therapy Industry Chain
- 12.2 Targeted Alpha-particle Therapy Upstream Analysis
- 12.3 Targeted Alpha-particle Therapy Midstream Analysis
- 12.4 Targeted Alpha-particle Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Targeted Alpha-particle Therapy. Industry analysis & Market Report on Targeted Alpha-particle Therapy is a syndicated market report, published as Global Targeted Alpha-particle Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Targeted Alpha-particle Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
